Skip to main content

MoneyWorks4Me

Medicamen Biotech informs about disclosures

23 Mar 2024 Evaluate
Medicamen Biotech has enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received from Growel Remedies sale of 2,00,000 equity shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.00
Dr. Reddys Labs. 1372.00
Cipla 1400.10
Lupin 2015.00
Zydus Lifesciences 1190.00
View more..